196 related articles for article (PubMed ID: 17496785)
1. The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.
Galore G; Azizi E; Scope A; Pavlotsky F; Yakobson E; Friedman E
Melanoma Res; 2007 Apr; 17(2):105-8. PubMed ID: 17496785
[TBL] [Abstract][Full Text] [Related]
2. MC1R variant alleles and malignant melanoma risk in Israel.
Galore-Haskel G; Azizi E; Mohamdi H; Scope A; Chaudru V; Laitman Y; Barak F; Pavlotsky F; Demenais F; Friedman E
Eur J Cancer; 2009 Jul; 45(11):2015-22. PubMed ID: 19269164
[TBL] [Abstract][Full Text] [Related]
3. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
4. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
5. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
6. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
7. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
8. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
9. MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population.
Fernandez L; Milne R; Bravo J; Lopez J; Avilés J; Longo M; Benítez J; Lázaro P; Ribas G
Carcinogenesis; 2007 Aug; 28(8):1659-64. PubMed ID: 17434924
[TBL] [Abstract][Full Text] [Related]
10. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
[TBL] [Abstract][Full Text] [Related]
11. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
[TBL] [Abstract][Full Text] [Related]
12. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
13. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
15. MC1R germline variants confer risk for BRAF-mutant melanoma.
Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
[TBL] [Abstract][Full Text] [Related]
16. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
17. Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.
Ozola A; Azarjana K; Doniņa S; Proboka G; Mandrika I; Petrovska R; Cēma I; Heisele O; Eņģele L; Streinerte B; Pjanova D
Cancer Genet; 2013 Mar; 206(3):81-91. PubMed ID: 23522749
[TBL] [Abstract][Full Text] [Related]
18. [Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms].
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012; 103(1):44-50. PubMed ID: 21737053
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Kanetsky PA; Rebbeck TR; Hummer AJ; Panossian S; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Culver HA; Zanetti R; Gallagher RP; Dwyer T; Busam K; From L; Mujumdar U; Wilcox H; Begg CB; Berwick M
Cancer Res; 2006 Sep; 66(18):9330-7. PubMed ID: 16982779
[TBL] [Abstract][Full Text] [Related]
20. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]